A federal judge in Rhode Island has issued a sweeping order preventing the Trump administration from cutting $11 billion in public health grants, a move that preserves critical funding for 23 states and the District of Columbia as legal proceedings continue. 19 May 2025
In a world where western firms increasingly seek to ingratiate themselves with Middle Eastern leaders and investors, a Saudi company has sought to curry favor with US President Donald Trump in an announcement on pharma manufacturing. 15 May 2025
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed HHS budget for fiscal year 2026 to the Senate Health, Education, Labor, and Pensions (HELP) Committee. 15 May 2025
US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the Department of Health and Human Services (HHS) and the biopharma industry, with the threat of a rule from the Centers for Medicare and Medicaid Services (CMS) to lower US drug prices if no deal is reached. 14 May 2025
US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices, a move that initially rattled investors but left many analysts unconvinced about its impact. 13 May 2025
US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market. 12 May 2025
UK-based pharma major AstraZeneca has started construction on a new manufacturing site for small molecule drugs in Wuxi, a city in East China's Jiangsu province, underscoring its deepening investment in the country. 12 May 2025
The UK government has announced a trade agreement with the USA. The UK-US Economic Prosperity Deal was agreed on Thursday May 8 with further details released on Friday May 9. 9 May 2025
UK pharma major AstraZeneca has suffered a setback in its legal fight to block the US government's efforts to lower prescription drug prices, after a federal appeals court dismissed its challenge to Medicare’s negotiation powers. 9 May 2025
As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical imports, Indian drug-maker stocks continue to take a hammering on the bourses. 8 May 2025
Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on its Section 232 investigation of pharmaceuticals and pharmaceutical ingredients imported to the USA. 8 May 2025
US President Donald Trump has signed an executive order attempting to restore a robust domestic manufacturing base for prescription drugs in the USA. 7 May 2025
In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in their domestic policy package that would tie Medicaid drug payments to the lowest prices paid in other wealthy countries, a White House official confirmed to Inside Health Policy. 5 May 2025
The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by the USA, are putting years of medical progress in jeopardy. 2 May 2025
A new report from Washington DC-based group No Patient Left Behind argues that foreign governments are underestimating the value of innovative medicines — a claim that adds fuel to the ongoing transatlantic debate on drug pricing and access. 2 May 2025
The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying it will now require all future vaccines to undergo testing in placebo-controlled trials before being approved for use. 2 May 2025
Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump issued an executive order establishing the Make America Healthy Again Commission. 1 May 2025
AstraZeneca posted a 10% rise in first-quarter revenue to $13.6 billion, supported by strong sales of cancer drugs and biopharmaceuticals. Core earnings per share climbed 21% to $2.49, while reported EPS advanced 34% to $1.88. Pre-tax profits increased 21% year-on-year to $3.4 billion. 29 April 2025
The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining childhood vaccination rates, published in JAMA. 28 April 2025
The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to those paid in other developed nations, according to a Reuters report citing multiple industry sources. 23 April 2025
A new initiative from the US Department of Health and Human Services (HHS) aims to make medications for pre-exposure prophylaxis (PrEP) available for free to people without insurance. 4 December 2019
The US medicines regulator has provided an update on its work to address the country’s ongoing opioid epidemic, leveraging new powers granted in 2018 under the SUPPORT Act. 25 October 2019
An important Congressional committee has approved House Speaker Nancy Pelosi’s pharmaceutical pricing bill, leading the way to further debate and an eventual vote in the US House of Representatives. 18 October 2019
US trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has raised objections to a drug pricing plan outlined by House Speaker Nancy Pelosi. 11 October 2019
The US National Institutes of Health (NIH) has awarded a grant of up to $4.6 million to Sydney University spinout Kinoxis Therapeutics, under an initiative aimed at combating the epidemic of opioid addiction in America. 30 September 2019
A year after the US Government passed controversial “Right to Try” legislation, the first contract research organizations (CRO) are gearing up to provide people with access to experimental medicines. 18 September 2019
More than $1.8 billion has been released by the US Department of Health and Human Services (HHS) to help combat the opioid crisis in the USA. 5 September 2019
US President Donald Trump is reviving a stalled effort to compel drugmakers to list drug prices in direct to consumer (DTC) advertising, after a court struck down the initiative. 22 August 2019
The recently-approved CAR-T therapies Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel) have come with a price tag to match the level of scientific innovation. 8 August 2019
The US Department of Health and Human Services (HHS) and the country’s Food and Drug Administration (FDA) have announced a plan to import certain prescription drugs in order to lower prices for patients. 31 July 2019
Shares in major pharmaceutical companies fell on Thursday, after the US government said it would abandon a proposal to require health insurers to pass significant rebates on to Medicare patients. 12 July 2019
Last month, the US Department of Health and Human Services (HHS) announced a new rule demanding that direct-to-consumer television advertisements for certain pharmaceuticals and biologics state the list price of the medicine being advertised. 17 June 2019
Amid multiple Congressional investigations into drug pricing in the USA, and a febrile political atmosphere around the role of the state in insurance and pricing negotiations, the nonpartisan Congressional Budget Office (CBO) released a report into so-called “Medicare for all” on Thursday. 2 May 2019
US Health Secretary Alex Azar has outlined progress combating the ongoing opioid crisis, with an update one year on from a pledge from the US President to reduce unnecessary opioid prescriptions, expand treatment, and boost access to naloxone. 25 April 2019
Most commercial executives in the industry thought the discussions over Obamacare were finally at an end, after a monthslong war of attrition between the White House and Congress early in Mr Trump’s presidency. They may need to think again. 27 March 2019
The US Food and Drug Administration has announced new final guidance on HIV prevention, following US President Donald Trump’s recently-announced effort to eliminate the HIV epidemic within America. 20 March 2019
Reflecting its growing standing as an opinion leader on all things drug price-related, the Institute for Clinical and Economic Review (ICER)—in collaboration with the Office of Health Economics (OHE) —has published a white paper looking at alternative models for pharmaceutical rebates in the USA. 13 March 2019
US President Donald Trump recently promised a cheering Miami crowd that America "will never be a socialist country." Let's hope!, writes Institute for Policy Innovation (IPI) resident scholar Dr Merrill Mathews. 9 March 2019